Webinar: Mother-To-Child Transmission of HBV

Date: Tuesday, September 16, 12:00 pm - 1:00 pm (EDT)

Moderator:  Peter Block, MD
Presenters:  Calvin Pan, MD, Robert Gish, MD

Mother-to-child transmission (MTCT) remains the predominant form of virological spread of hepatitis B worldwide. Effective tools to mitigate MTCT exist, but are heterogeneously implemented. Innovations to the standard regimen have recently illustrated simplified approaches to MTCT prevention that could be more effectively adopted, particularly in resource-limited settings.

The webinar will provide a concise review of current standard of care, including an overview of AASLD guidelines. A high-yield discussion on the evolving literature of antiviral therapies utilized in pregnancy would also be included, including a synopsis on the recent clinical trial in JAMA demonstrating benefit with use of tenofovir disoproxil fumarate (TDF) in early pregnancy.

Learning Objectives:
Upon completion of this activity, a participant should be able to:
-Identify the current standard of care to mitigate mother-to-child transmission (MTCT) of HBV
-Describe the standard of care to curtail MTCT?
-Define how and when the anti-viral therapy should be used and started in pregnancy